首页> 外文期刊>Transplantation reviews >Kidney paired exchange and desensitization: Strategies to transplant the difficult to match kidney patients with living donors
【24h】

Kidney paired exchange and desensitization: Strategies to transplant the difficult to match kidney patients with living donors

机译:肾脏配对交换和脱敏:移植难以匹敌肾脏患者的策略

获取原文
获取原文并翻译 | 示例
           

摘要

With organs in short supply, only a limited number of kidney transplants can be performed a year. Live donor donation accounts for 1/3rd of all kidney transplants performed in the United States. Unfortunately, not every donor recipient pair is feasible because of Human leukocyte antigen (HLA) sensitization and ABO incompatibility. To overcome these barriers to transplant, strategies such as kidney paired donation (KPD) and desensitization have been developed. KPD is the exchange of donors between at least two incompatible donor-recipient pairs such that they are now compatible. Desensitization is the removal of circulating donor specific antibodies to prevent graft rejection. Regardless of the treatment strategy, highly sensitized patients whose calculated panel reactive antibody (cPRA) is >= 95% remain difficult to transplant with match rates as low as 15% in KPD pools. Desensitization has proved to be difficult in those with high antibody titers. A novel approach is the combination of both KPD and desensitization to facilitate compatible and successful transplantation. A highly sensitized patient can be paired with a better immunological match in the KPD pool and subsequently desensitized to a lesser degree. This article reviews the current progress in KPD and desensitization and their use as a combined therapy. (C) 2017 Elsevier Inc. All rights reserved.
机译:随着器官供不应求,只有有限数量的肾移植可以进行一年。 Live捐赠捐赠占美国肾脏移植的1/3次。不幸的是,由于人白细胞抗原(HLA)敏化和不相容性,而不是每个捐助者接受者对都是可行的。为了克服移植的这些障碍,已经开发出肾配对捐赠(KPD)和脱敏等策略。 KPD是在至少两个不相容的捐助者对之间交换捐赠者,以便它们现在兼容。脱敏是去除循环供体特异性抗体以防止移植物排斥。无论治疗策略如何,高度敏感的患者,其计算的面板反应抗体(CPRA)> = 95%仍然难以移植在KPD池中的比例低至15%。在具有高抗体滴度的那些中证明了脱敏中难以脱敏。一种新的方法是KPD和脱敏的组合,以促进相容和成功的移植。高敏化的患者可以与KPD池中的更好的免疫匹配配对,随后脱敏于较小程度。本文审查了KPD和脱敏的目前的进展及其作为组合治疗的用途。 (c)2017年Elsevier Inc.保留所有权利。

著录项

  • 来源
    《Transplantation reviews》 |2017年第1期|共6页
  • 作者单位

    Univ Southern Calif Keck Sch Med Dept Surg Div Hepatobilicuy Surg &

    Abdominal Transplantat 1510;

    Stanford Univ Sch Med Dept Surg Div Abdominal Transplantat 750 Welch Ave Suite 200 Palo Alto;

    Stanford Univ Sch Med Dept Surg Div Abdominal Transplantat 750 Welch Ave Suite 200 Palo Alto;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号